Rani Therapeutics Holdings (RANI) Operating Margin (QoQ) (2020 - 2026)

Rani Therapeutics Holdings (RANI) Operating Margin (QoQ) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.70 Bn	131.85 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.74 Bn	78.75 Bn	3.93 Bn
3	Argenx Se	65.36 Bn	60.18 Bn	1.37 Bn
4	Moderna	59.15 Bn	54.01 Bn	52.00 Mn
5	BeOne Medicines	42.12 Bn	37.02 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.88 Bn	28.57 Bn	992.69 Mn
7	BioNTech SE	28.14 Bn	9.75 Bn	668.28 Mn
8	Insmed	27.59 Bn	26.43 Bn	358.27 Mn
9	Royalty Pharma	27.31 Bn	26.48 Bn	-
10	Rani Therapeutics Holdings	164.41 Mn	164.41 Mn	-

Download Data